My Cart [ 0 ]
Home > Antibodies > A-Z Primary Antibodies > Human B7-2 Protein

Human B7-2 Protein

CD86 molecule; CD86; B70; B7-2 antigen; B72; B7-2; BU63; FUN-1; LAB72; MGC34413; CD28LG2

Catalog No. Product Name Size List Price (US$) Quantity
BP005301 Human B7-2/CD86 Protein with the C-hFc Tag 100UG 195.00
BP005301 Human B7-2/CD86 Protein with the C-hFc Tag 500UG 650.00
BP005656 Human B7-2/CD86 Protein with the C-His-Avi Tag 100UG 225.00
BP005656 Human B7-2/CD86 Protein with the C-His-Avi Tag 500UG 750.00
BP005301 Human B7-2/CD86 Protein with the C-hFc Tag 100UG 195.00
BP005301 Human B7-2/CD86 Protein with the C-hFc Tag 500UG 650.00
BP005656 Human B7-2/CD86 Protein with the C-His-Avi Tag 100UG 225.00
BP005656 Human B7-2/CD86 Protein with the C-His-Avi Tag 500UG 750.00
Description

BP005301: Human B7-2/CD86 Protein with the C-hFc Tag

Source: The recombinant Human B7-2/CD86 Protein, (amino acids Leu26-Pro247) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human B7-2/CD86 protein with the hFc tag at the C-terminus has a predicted MW of 52 kDa. Due to glycosylation, the protein migrates to 75-90 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human CTLA-4 protein with the C-hFc tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human B7-2 protein with the C-hFc tag with the EC50 of 125.7 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human B7-2/CD86 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.

BP005656: Human B7-2/CD86 Protein with the C-His-Avi Tag

Source: The recombinant Human B7-2/CD86 Protein, (amino acids Leu26-Pro247) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human B7-2/CD86 protein with the His-Avi tag at the C-terminus has a predicted MW of 28.2 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result.
Activity: Immobilized recombinant Human B7-2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human CTLA-4 protein with the C-hFc tag with the EC50 of 0.12 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human B7-2/CD86 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.


Shipping: The recombinant Human B7-2/CD86 Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 week, 2 to 8°C under sterile conditions after reconstitution.
6 months, -20 to -70°C under sterile conditions after reconstitution.

Related Links

See our Privacy Policy